케모포트(Chemoport)를 가지고 있는 암 환자의 헤파린액 관류주기 연장에 대한 근거기반간호 사례

• 영문명: Evidence-based Nursing Case on Extended Heparin Flushing Interval for Cancer Patients with a Chemoport
• 발행기관: 한국근거기반간호학회
• 저자명: 최은석 최은경 이미주 정혜련 김정혜 임은영
• 간행물 정보: 『근거와 간호』제12권 제1호, 42~49쪽, 전체 8쪽
• 주제분류: 의약학 > 간호학
• 파일형태: PDF
• 발행일자: 2024.12.31

국문 초록

Purpose: This study aimed to evaluate the safety and feasibility of extending the flushing interval beyond 4 weeks in adult cancer patients with chemoports. Methods: A literature search was conducted in online databases covering studies published between 2000 and 2021. Four reviewers independently performed a quality assessment of the selected studies. Additionally, a single-center retrospective study was conducted, analyzing the medical records of cancer patients who had completed chemotherapy and continued periodic heparin flushing for port maintenance from January 2018 to December 2022. Results: An assessment of 12 studies using the Scottish Intercollegiate Guidelines Network (SIGN) tool indicated that extending heparin flushing intervals to 8 weeks is supported by Grade B evidence, while intervals beyond 12 weeks are supported by Grade C evidence. The retrospective study revealed no significant differences in occlusion or infection rates when extending flushing intervals to 12 weeks compared to the standard 4-week interval, with a cumulative complication incidence of 3.4%. Conclusion: Extending chemoport flushing intervals to up to three months in adult cancer patients is safe and feasible, with no increased risk of infection or occlusion. Further research is recommended to include larger sample sizes and to evaluate the potential applicability of these findings to pediatric patients.

목차

서 론

연구방법

연구결과

논 의

결 론

REFERENCES

키워드

Chemoport Flushing Interval Infection Occlusion Evidence-based practice